Antitumor compositions and methods
US5254582A · kind A · utility
8Cited by
9References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 5, 1992 |
| Grant date | Oct 19, 1993 |
| Priority date | — |
| Expiry date | Feb 5, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention provides the use of N-[[(3,4-dichlorophenyl)amino]carbonyl]-2,3-dihydrobenzofuran-5-sulfonamid e, and pharmaceutically acceptable salts thereof, in the treatment of susceptible neoplasms in mammals. This invention further provides the novel aforementioned compound and its pharmaceutical formulations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.